Several companies, including Medra, Google DeepMind, and Dyno GATC, are developing ai agents and technologies to automate scientific discovery, particularly in the field of drug discovery. These advancements may potentially accelerate the discovery process and impact the pharmaceutical industry. The use of ai in scientific research appears to be a growing trend, with various companies announcing new technologies and partnerships in this area.